Hi, what are you looking for?
– We learned officially today that Jeremy Levin CEO is leaving Teva behind and has resigned.Jewish Business News reported yesterday on a purported row...
– Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) is Israel’s largest and most successful public company. As such what it does, and how it thinks, become...
– Jeremy Levin has threatened to resign because of interference by the board of directors. – Jeremy Levin – Israeli Channel 2 News reports...
– The plant will increase production capacity in the country to two billion tablets and capsules a year. – – Teva Pharmaceutical Industries Ltd. (NYSE: TEVA;...
– Russia’s Federal Antimonopoly Service: Teva’s refusal to supply Copaxone is neither justified economically nor technologically. – Teva’s Copaxone – /By Shiri Habib-Valdhorn and...
– Teva says it will shed 10% of its workforce by the end of 2014 and hundreds of employees in Israel will lose their...
– The District Court of the Hague (Netherlands) rejected a patent revocation suit brought by Mylan’s Dutch unit. – – The District Court of...
– Teva will disclose the salaries and compensation of its top executives on an individual basis, not as an aggregate amount. – /Ela Levy-Weinrib/...
– Teva sees the court preventing Mylan from launching its generic version of the Parkinson’s treatment before 2017. – – Teva Pharmaceutical Industries Ltd....
– Results from Final Phase III Study of in Patients with Major Depression Associated with Bipolar I Disorder failed to show that it was...